Omnicell vs Veeva Systems
Veeva Systems reported revenue of $3.2 billion in fiscal 2026, 2.7 times Omnicell's $1.2 billion in fiscal 2025. Omnicell's revenue grew 6.5% in its latest year, and Veeva Systems' grew 16.3%. Omnicell had an operating margin of 0.4%, against 28.7% at Veeva Systems. Free cash flow was $87 million at Omnicell and $1.4 billion at Veeva Systems. Their fiscal years end in different months (December 31 and January 31), so the periods don't line up exactly.
Side by side
| Omnicell | Veeva Systems | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2026, Jan 31, 2026 |
| Revenue | $1.2B | $3.2B |
| Revenue growth | 6.5% | 16.3% |
| Revenue growth a year, last 5 years | 5.8% | 16.9% |
| Gross margin | 42.5% | 75.5% |
| Operating margin | 0.4% | 28.7% |
| Net margin | 0.2% | 28.4% |
| Free cash flow | $87M | $1.4B |
| Free cash flow margin | 7.3% | 43.4% |
| Return on capital | 0.2% | — |
| Net debt to EBITDA | −0.3x | −6.9x |
| Dividends and buybacks | $78M | $170M |
| Change in diluted share count | 0.2% | 1.1% |
| Last close | $37.34 | $303.73 |
| P/E at the last close | 38.9× | 49.7× |
| Insider trades, last 12 months | sold $3.0 million | sold $16.8 million |
| Piotroski F-score | 6 of 9 | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
OmnicellVeeva Systems
Operating margin
Percent of revenue
OmnicellVeeva Systems
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
OmnicellVeeva Systems
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Omnicell and Veeva Systems pages.